Global Editions

FDA Approves Groundbreaking Gene Therapy for Cancer

The treatment will be sold by Novartis for $475,000.
By Emily Mullin

A revolutionary cancer therapy that uses genetically engineered immune cells has been approved by the U.S. Food and Drug Administration, ushering in a new era of cancer treatment. The FDA calls the treatment, made by Novartis, the “first gene therapy” in the U.S…

Read more on technologyreview.com.

اسے اردو میں پڑھیں

Tags:
Authors

Related posts

Top